StockData
Sera Prognostics, Inc. logo

Sera Prognostics, Inc. (SERA) stock

SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30
$2.00+0.06 (+3.09%)

Close on Nov 17, 2026Market cap $78.90MP/E –Yield –

Sera Prognostics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Sera Prognostics's operating income for the twelve months ending Jun 30, 2026 was -$37.30M. For fiscal 2025 it was -$36.50M. The highest annual figure on record is -$17.97M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$36.50M–
FY2024Dec 31, 2024-$36.64M–
FY2023Dec 31, 2023-$39.82M–
FY2022Dec 31, 2022-$45.65M–
FY2021Dec 31, 2021-$35.40M–
FY2020Dec 31, 2020-$17.97M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$10.00M–
Q1 FY2026Mar 31, 2026-$9.36M–
Q4 FY2025Dec 31, 2025-$8.95M–
Q3 FY2025Sep 30, 2025-$8.98M–
Q2 FY2025Jun 30, 2025-$9.32M–
Q1 FY2025Mar 31, 2025-$9.25M–
Q4 FY2024Dec 31, 2024-$9.42M–
Q3 FY2024Sep 30, 2024-$8.86M–
Q2 FY2024Jun 30, 2024-$9.25M–
Q1 FY2024Mar 31, 2024-$9.10M–
Q4 FY2023Dec 31, 2023-$8.85M–
Q3 FY2023Sep 30, 2023-$8.18M–
Q2 FY2023Jun 30, 2023-$11.46M–
Q1 FY2023Mar 31, 2023-$11.33M–
Q4 FY2022Dec 31, 2022-$10.42M–
Q3 FY2022Sep 30, 2022-$11.19M–
Q2 FY2022Jun 30, 2022-$11.75M–
Q1 FY2022Mar 31, 2022-$12.30M–
Q4 FY2021Dec 31, 2021-$12.55M–
Q3 FY2021Sep 30, 2021-$9.44M–
Q2 FY2021Jun 30, 2021-$7.38M–
Q1 FY2021Mar 31, 2021-$6.03M–
Q4 FY2020Dec 31, 2020-$4.75M–
Q3 FY2020Sep 30, 2020-$4.64M–
Q2 FY2020Jun 30, 2020-$4.28M–

More Sera Prognostics figures

See a number that looks wrong?